Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.
While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.
Is This 1 Momentum Stock a Screaming Buy Right Now?
For momentum investors, upward or downward trends in a stock's price or earnings outlook take precedent, so they'll want to zero in on the Momentum Style Score. This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
Hims & Hers Health, Inc. (HIMS)
San Francisco, CA-based Hims & Hers Health, Inc. is a consumer-centric health and wellness platform that redefines healthcare through personalized solutions and seamless digital access. Launched in 2017, the company specializes in subscription-based services and retail partnerships, catering to a broad range of health needs across key therapeutic categories. The company operates under dual revenue streams — online subscriptions and wholesale retail.
HIMS sits at a Zacks Rank #2 (Buy), holds a Momentum Style Score of A, and has a VGM Score of A. The stock is up 14% and up 115.1% over the past one-week and four-week period, respectively, and Hims & Hers Health, Inc. has gained 317.2% in the last one-year period as well. Additionally, an average of 54,930,668 shares were traded over the last 20 trading sessions.
A company's earnings performance is important for momentum investors as well. For fiscal 2025, seven analysts revised their earnings estimate higher in the last 60 days for HIMS, while the Zacks Consensus Estimate has increased $0.09 to $0.72 per share. HIMS also boasts an average earnings surprise of 19.6%.
HIMS should be on investors' short list because of its impressive earnings fundamentals, a good Zacks Rank, and strong Momentum and VGM Style Scores.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
